Plasma concentrations, behavioural and physiological effects following intravenous and intramuscular detomidine in horses

Equine Vet J. 2009 Nov;41(8):772-7. doi: 10.2746/042516409x421624.

Abstract

Reasons for performing study: Detomidine hydrochloride is used to provide sedation, muscle relaxation and analgesia in horses, but a lack of information pertaining to plasma concentration has limited the ability to correlate drug concentration with effect.

Objectives: To build on previous information and assess detomidine for i.v. and i.m. use in horses by simultaneously assessing plasma drug concentrations, physiological parameters and behavioural characteristics.

Hypothesis: Systemic effects would be seen following i.m. and i.v. detomidine administration and these effects would be positively correlated with plasma drug concentrations.

Methods: Behavioural (e.g. head position) and physiological (e.g. heart rate) responses were recorded at fixed time points from 4 min to 24 h after i.m. or i.v. detomidine (30 microg/kg bwt) administration to 8 horses. Route of administration was assigned using a balanced crossover design. Blood was sampled at predetermined time points from 0.5 min to 48 h post administration for subsequent detomidine concentration measurements using liquid chromatography-mass spectrometry. Data were summarised as mean +/- s.d. for subsequent analysis of variance for repeated measures.

Results: Plasma detomidine concentration peaked earlier (1.5 min vs. 1.5 h) and was significantly higher (105.4 +/- 71.6 ng/ml vs. 6.9 +/- 1.4 ng/ml) after i.v. vs. i.m. administration. Physiological and behavioural changes were of a greater magnitude and observed at earlier time points for i.v. vs. i.m. groups. For example, head position decreased from an average of 116 cm in both groups to a low value 35 +/- 23 cm from the ground 10 min following i.v. detomidine and to 64 +/- 24 cm 60 min after i.m. detomidine. Changes in heart rate followed a similar pattern; low value of 17 beats/min 10 min after i.v. administration and 29 beats/min 30 min after i.m. administration.

Conclusions: Plasma drug concentration and measured effects were correlated positively and varied with route of administration following a single dose of detomidine.

Potential relevance: Results support a significant influence of route of administration on desirable and undesirable drug effects that influence case management.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Female
  • Heart Rate / drug effects
  • Horses*
  • Hypnotics and Sedatives / administration & dosage*
  • Hypnotics and Sedatives / blood
  • Hypnotics and Sedatives / pharmacokinetics
  • Hypnotics and Sedatives / pharmacology*
  • Imidazoles / administration & dosage*
  • Imidazoles / blood
  • Imidazoles / pharmacokinetics
  • Imidazoles / pharmacology*
  • Injections, Intramuscular
  • Injections, Intravenous
  • Male
  • Pain / prevention & control
  • Pain Measurement / veterinary
  • Respiration / drug effects
  • Time Factors

Substances

  • Hypnotics and Sedatives
  • Imidazoles
  • detomidine